Europe Formulation CDMO Services Market was valued at USD 10.3 Billion in 2022 and is projected to reach USD 16.3 Billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030.
The Europe Formulation CDMO Services Market has seen substantial growth in recent years, driven by an increasing demand for outsourced drug development and manufacturing services. As pharmaceutical companies focus on their core competencies, they are turning to Contract Development and Manufacturing Organizations (CDMOs) to handle critical stages of the drug development process. This shift allows companies to save on infrastructure costs and reduce the time-to-market for new drugs.
Formulation CDMO services are integral in transforming a chemical compound into an effective, safe, and market-ready product. These services span various stages, from early-stage development to final commercial production. With the growing complexity of modern therapeutics, including biologics and biosimilars, formulation CDMOs in Europe are under increasing pressure to offer specialized solutions that align with both regulatory standards and innovative manufacturing techniques.
One of the primary requirements from industries within the Formulation CDMO Services Market is advanced technical expertise. Companies in the pharmaceutical, biotechnology, and nutraceutical industries demand CDMOs with capabilities in developing high-quality formulations that maintain efficacy while adhering to regulatory guidelines. The need for personalized medicine and patient-centric solutions further escalates the demand for specialized formulation services tailored to specific therapeutic areas.
Additionally, regulatory compliance remains a crucial factor driving the demand for these services. The stringent regulations across European countries, including Good Manufacturing Practices (GMP) and other international quality standards, necessitate that CDMOs ensure their facilities are equipped to meet these requirements. European pharmaceutical companies are particularly focused on ensuring their CDMO partners can navigate these complex regulations to prevent costly delays in product launches.
Flexibility in production capacity is also vital, as companies in the market require CDMOs that can quickly adapt to changing market demands, especially with the rise of biologic and personalized drug formulations. This demand for scalable production, alongside rapid prototyping and formulation adjustments, has led to a more competitive Formulation CDMO Services Market across Europe.
Moreover, as the biotechnology landscape continues to evolve, CDMOs are expected to provide innovative and cost-effective solutions for drug manufacturing, with a strong emphasis on sustainability and minimizing environmental impact. This aligns with the growing trend of green manufacturing, which is becoming increasingly important for European businesses striving for environmental stewardship.
Get an In-Depth Research Analysis of the Europe Formulation CDMO Services Market Size And Forecast [2025-2032]
Â
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Zhejiang Langhua Pharmaceutical
Viva Biotech
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Formulation CDMO Services Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Formulation CDMO Services Market
Solid Formulations
Liquid Formulations
Semi-Solid Formulations
Injectable Formulations
Specialty Formulations
Pharmaceuticals
Biotechnology
Nutraceuticals
Cosmetics and Personal Care
Food and Beverage
Contract Development
Contract Manufacturing
Analytical Services
Stability Testing
Regulatory Services
Small Molecules
Large Molecules
Biologics
Oral Dosage Forms
Topical Dosage Forms
Preclinical
Clinical
Commercial
Scale-Up Services
Custom Manufacturing
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ Formulation CDMO Services Market Research Analysis
1. Introduction of the Europe Formulation CDMO Services Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Formulation CDMO Services Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Formulation CDMO Services Market, By Type
6. Europe Formulation CDMO Services Market, By Application
7. Europe Formulation CDMO Services Market, By Geography
Europe
Germany
UK
France
8. Europe Formulation CDMO Services Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/